Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

onsite: An Integrated Framework for Phosphosite Localization and False Localization Rate Estimation

Created on 13 Jul 2026

Authors

Yue, Q.-X., Wei, Z., Dai, C., Bai, M., Perez-Riverol, Y., Sachsenberg, T.

Abstract

With the rapid development of mass spectrometry-based proteomics, the volume of phosphoproteomic data has increased substantially. However, accurate localization of phosphorylation sites and standardized statistical validation remain critical analytical bottlenecks. To address the lack of standardized cross-algorithm evaluation, we introduce onsite, a unified and open-source Python framework. onsite integrates an alanine-decoy strategy to estimate the false localization rate (FLR) across three algorithms: AScore, PhosphoRS, and pyLucXor. This modular architecture efficiently processes large-scale datasets and enables global FLR calculation. Benchmarking on the standard synthetic phosphopeptide dataset PXD000138 highlighted distinct inter-algorithmic variations. Using the same 5% global FLR threshold, pyLucXor localized the most target sites (28,353). It also reached a high accuracy (91.22%) against the known ground truth, resulting in the largest number of correctly localized sites (25,865). Reanalysis of the highly fractionated, large-scale PXD012255 dataset further demonstrated that native integration of onsite into the quantms pipeline enables scalable processing and provides a standardized framework for FLR control in large-scale phosphoproteomics.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 13 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement